Assenagon Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Assenagon Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-542,817	Closed	-$28M	–	1508
2022 Q3	$28M	Buy	542,817 +403,598	+290%	+$16.7M	0.11%	188
2022 Q2	$3.45M	Sell	139,219 -22,556	-14%	-$497K	0.01%	656
2022 Q1	$4.06M	Sell	161,775 -69,687	-30%	-$1.96M	0.01%	588
2021 Q4	$8.43M	Buy	+231,462	New	+$8.13M	0.02%	369
2021 Q3	–	Sell	-104,213	Closed	-$1.4M	–	1468
2021 Q2	$1.4M	Buy	+104,213	New	+$2.57M	﹤0.01%	811
2021 Q1	–	Sell	-49,294	Closed	-$3.05M	–	1352
2020 Q4	$3.05M	Buy	49,294 +39,186	+388%	+$2.24M	0.01%	439
2020 Q3	$554K	Buy	+10,108	New	+$544K	﹤0.01%	954
2019 Q4	–	Sell	-124,328	Closed	-$843K	–	989
2019 Q3	$843K	Buy	+124,328	New	+$933K	0.01%	584

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Assenagon Asset Management's CCXI Position: Q4 2022 in Review

Assenagon Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 542,817 shares — an estimated $28M sold.

Assenagon Asset Management first reported a position in CCXI in Q3 2019 and held it in 8 quarters. The position peaked at $28M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Assenagon Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Assenagon Asset Management sold 542,817 ChemoCentryx, Inc. shares in Q4 2022, an estimated $28M.
Assenagon Asset Management first reported a position in ChemoCentryx, Inc. in Q3 2019 and held it in 8 quarters.
Assenagon Asset Management's ChemoCentryx, Inc. position peaked at $28M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.